Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions

Kazuko Okamoto-Shibayama1, Yutaka Sato, Toshifumi Azuma

  • 1Department of Biochemistry and Oral Health Science Center HRC7, Tokyo Dental College, Mihama-ku, Chiba City, Japan. okamotok@tdc.ac.jp

Insights

Resveratrol, a natural compound, effectively inhibits the growth and virulence of Candida albicans, a common fungal pathogen. This study shows resveratrol disrupts key fungal development, offering potential for new antifungal therapies.

Area of Science:

  • Mycology
  • Pharmacology
  • Infectious Diseases

Background:

  • Candida albicans is a human fungal pathogen whose virulence is linked to its morphological transition from yeast to hyphal forms.
  • Resveratrol, a polyphenolic compound found in plants, has demonstrated various pharmacological effects, including potential antimicrobial properties.

Purpose of the Study:

  • To investigate the antifungal activity of resveratrol against Candida albicans.
  • To determine if resveratrol affects the morphological transition of C. albicans.

Main Methods:

  • Culturing of Candida albicans in yeast and mycelial forms.
  • Treatment of C. albicans cultures with varying concentrations of resveratrol.
  • Microscopic observation and growth assays to assess fungal morphology and growth inhibition.

Main Results:

  • Resveratrol significantly inhibited both yeast-form and mycelial growth of C. albicans.
  • Resveratrol impaired the yeast-to-hypha transition of C. albicans under various inducing conditions (serum, pH, nutrients).
  • Normal filamentation of C. albicans was disrupted by resveratrol treatment.

Conclusions:

  • Resveratrol exhibits potent antifungal activity against Candida albicans.
  • Resveratrol interferes with the crucial morphological transition of C. albicans, suggesting a mechanism for its virulence inhibition.
  • Resveratrol represents a promising candidate for the development of novel antifungal strategies against C. albicans infections.